AI Verdict
HOMB has stronger fundamentals based on our AI analysis.
HOTH vs HOMB Fundamental Comparison
| Metric | HOTH | HOMB |
|---|---|---|
| Revenue | $1.2B | $1.3B |
| Net Income | $-12.5M | $475.4M |
| Net Margin | -1.0% | 37.2% |
| ROE | -202.7% | 11.1% |
| ROA | -164.0% | 2.1% |
| Current Ratio | 4.72x | N/A |
| Debt/Equity | 0.00x | 0.30x |
| EPS | $-0.90 | $2.41 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HOTH vs HOMB: Frequently Asked Questions
Is HOTH or HOMB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HOMB has stronger fundamentals. HOTH is rated STRONG SELL (88% confidence) while HOMB is rated BUY (72% confidence). This is not investment advice.
How does HOTH compare to HOMB fundamentally?
Hoth Therapeutics, Inc. has ROE of -202.7% vs HOME BANCSHARES INC's 11.1%. Net margins are -1.0% vs 37.2% respectively.
Which stock pays higher dividends, HOTH or HOMB?
HOTH has a dividend yield of N/A or no dividend while HOMB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HOTH or HOMB for long term?
For long-term investing, consider that HOTH has STRONG SELL rating with 88% confidence, while HOMB has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HOTH vs HOMB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HOTH vs HOMB, the AI consensus favors HOMB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.